Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

NCT05813275 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

646

Enrollment

INDUSTRY

Sponsor class

Conditions

OSA

Interventions

DRUG: AD109
DRUG: Placebo

Sponsor

Apnimed